Evolus (EOLS) Goodwill & Intangibles (2017 - 2026)
Evolus' (EOLS) quarterly Goodwill & Intangibles came in at $67.9 million in Q1 2026, down 3.71% YoY from $70.6 million in Q1 2025, and down 1.88% on a QoQ basis from $69.2 million in Q4 2025.
Evolus (EOLS) Goodwill & Intangibles (2017 - 2026) Analysis & Trends
Evolus (EOLS) has 10 years of Goodwill & Intangibles data on file, last reported at $67.9 million in Q1 2026.
- Quarterly Goodwill & Intangibles fell 3.71% year-over-year to $67.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $67.9 million (down 3.71% YoY) and the FY2025 annual result came in at $69.2 million, down 1.02% from the prior year.
- Goodwill & Intangibles slipped to $67.9 million in Q1 2026, from $69.2 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $71.2 million in Q1 2022 to a low of $67.5 million in Q2 2024.
- A 5-year average of $69.2 million and a median of $69.2 million in 2025 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2022 — Goodwill & Intangibles retreated 4.73% — and 2025, when it grew 4.55%.
- Tracing EOLS's Goodwill & Intangibles over 5 years: stood at $69.8 million in 2022, then fell by 2.13% to $68.3 million in 2023, then grew by 2.41% to $70.0 million in 2024, then retreated by 1.02% to $69.2 million in 2025, then declined by 1.88% to $67.9 million in 2026.
- The last three Goodwill & Intangibles figures came in at $67.9 million (Q1 2026), $69.2 million (Q4 2025), and $69.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Evolus | 552.49 Mn | 507.32 Mn | 57.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 66.90 Mn |
| Mar 31, 2026 | 67.95 Mn |
| Dec 31, 2025 | 69.25 Mn |
| Sep 30, 2025 | 69.93 Mn |
| Jun 30, 2025 | 70.56 Mn |
| Mar 31, 2025 | 70.57 Mn |
| Dec 31, 2024 | 69.96 Mn |
| Sep 30, 2024 | 67.80 Mn |
| Jun 30, 2024 | 67.48 Mn |
| Mar 31, 2024 | 67.80 Mn |
| Dec 31, 2023 | 68.32 Mn |
| Sep 30, 2023 | 67.71 Mn |
| Jun 30, 2023 | 68.42 Mn |
| Mar 31, 2023 | 69.14 Mn |
| Dec 31, 2022 | 69.81 Mn |
| Sep 30, 2022 | 70.32 Mn |
| Jun 30, 2022 | 70.62 Mn |
| Mar 31, 2022 | 71.24 Mn |
| Dec 31, 2021 | 71.83 Mn |
| Sep 30, 2021 | 72.68 Mn |